Skip to content

Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06507007
Acronym
EPIHEAR
Enrollment
150
Registered
2024-07-18
Start date
2025-02-01
Completion date
2027-07-30
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inner Ear Disease, Sensorineural Hearing Loss, Turner Syndrome

Keywords

Epigenetics, Sensorineural hearing loss, Turner Syndrome, Inner Ear Dysfunction

Brief summary

The goal of this case-control study is to pave the way for new revolutionary treatment measures within hearing loss that could either replace or delay the need for hearing aids. The study focuses on people with Turner syndrome (TS). The aim is to find out if there are specific DNA methylation patterns and/or RNA expression profiles linked to sensorineural hearing loss (SNHL) in people with TS. Additionally, the structure and function of the inner ear in these individuals will be examined to see if there is a connection to their epigenetic profile. The main question it aims to answer is: Does epigenetics constitute a common denominator for some of the unexplained SNHL cases? Turner Syndrome (TS) represents an ideal model for studying epigenetics related to sensorineural hearing loss (SNHL). Participants will undergo the following tests: * Ear examinations * Hearing tests * Balance tests * Blood tests * MRI scans * CBCT (cone-beam computed tomography) scans

Interventions

None listed

Sponsors

Gødstrup Hospital
Lead SponsorOTHER
University of Aarhus
CollaboratorOTHER
Aarhus University Hospital
CollaboratorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 18 and 60 years old

Exclusion criteria

* Contraindications for the MRI or CBCT * Serious medical disorders * Neurological or psychiatric disorders of any kind * Use of medication that is known to influence inner ear function * Medical history with dizziness or hearing problems (controls only)

Design outcomes

Primary

MeasureTime frameDescription
Epigenetic profile2024-2026DNA methylation analyses are conducted on the purified DNA. RNA expression analyses and ChIP-seq are performed on the purified RNA. Based on this, the epigenetic profile will be mapped to identify consistent differences associated with SNHL.

Secondary

MeasureTime frameDescription
Hearing ability2024-2026Hearing level thresholds and bone conduction is assesed by pure tone audiometry.
Vestibular status2024-2026The vestibular function is assessed using the video head impulse test (vHIT), vestibular evoked myogenic potentials, and posturography.
Structural malformations2024-2026Anatomy and inner ear malformations are examined using Conebeam CT and MRI.

Countries

Denmark

Contacts

CONTACTLouise Hill-Madsen, MD
lohill@rm.dk20282635
PRINCIPAL_INVESTIGATORTherese Ovesen, Prof

University Clinic of Flavour, Balance and Sleep

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026